Payment overview · 2025
General Payments
$32.39
2 reported records · 2 companies
Healthcare provider profile · identity verified
Daniel M. Schmidt, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · RICHLAND, MO · NPI 1356472476
Verified facts
What the public records show
CMS Open Payments records show Daniel M. Schmidt, M.D. received $32.39 in general payments during 2025 across 2 reported records.
Dexcom, Inc. accounted for 54.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 48 claims for Synthroid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $17.54 | 54.1% | 1 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $14.85 | 45.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $32.39 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $17.54 | 1 | 2025 |
Source payment records
|
|||||
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $14.85 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
48 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 457 | 55 |
| Lisinopril | Lisinopril | 357 | 65 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 350 | 48 |
| Atorvastatin Calcium | Atorvastatin Calcium | 333 | 47 |
| Gabapentin | Gabapentin | 284 | 40 |
| Furosemide | Furosemide | 279 | 31 |
| Clonazepam | Clonazepam | 270 | 30 |
| Amlodipine Besylate | Amlodipine Besylate | 252 | 50 |
| Pantoprazole Sodium | Pantoprazole Sodium | 249 | 28 |
| Metformin Hcl | Metformin Hcl | 237 | 34 |
| Oxycodone Hcl | Oxycodone Hcl | 230 | 26 |
| Potassium Chloride | Potassium Chloride | 226 | 23 |
| Alprazolam | Alprazolam | 215 | 27 |
| Omeprazole | Omeprazole | 203 | 34 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 202 | 30 |
| Metoprolol Tartrate | Metoprolol Tartrate | 197 | 25 |
| Tramadol Hcl | Tramadol Hcl | 181 | 28 |
| Famotidine | Famotidine | 174 | 22 |
| Mirtazapine | Mirtazapine | 172 | 18 |
| Pregabalin | Pregabalin | 162 | 25 |
| Trazodone Hcl | Trazodone Hcl | 161 | 24 |
| Pioglitazone Hcl | Pioglitazone Hcl | 160 | 23 |
| Meloxicam | Meloxicam | 157 | 25 |
| Eliquis | Apixaban | 153 | 17 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 152 | 39 |
| Amitriptyline Hcl | Amitriptyline Hcl | 152 | 21 |
| Citalopram Hbr | Citalopram Hydrobromide | 137 | 12 |
| Metoprolol Succinate | Metoprolol Succinate | 137 | 16 |
| Tizanidine Hcl | Tizanidine Hcl | 137 | 24 |
| Losartan Potassium | Losartan Potassium | 136 | 25 |
| Tamsulosin Hcl | Tamsulosin Hcl | 136 | 19 |
| Donepezil Hcl | Donepezil Hcl | 134 | 12 |
| Metformin Hcl Er | Metformin Hcl | 130 | 20 |
| Sertraline Hcl | Sertraline Hcl | 121 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 117 | 20 |
| Simvastatin | Simvastatin | 117 | 20 |
| Hydrochlorothiazide | Hydrochlorothiazide | 110 | 24 |
| Quetiapine Fumarate | Quetiapine Fumarate | 107 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 99 | suppressed |
| Celecoxib | Celecoxib | 95 | 11 |
| Montelukast Sodium | Montelukast Sodium | 94 | 16 |
| Baclofen | Baclofen | 93 | 12 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 86 | 13 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 85 | 21 |
| Atenolol | Atenolol | 84 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 84 | 12 |
| Buspirone Hcl | Buspirone Hcl | 81 | 13 |
| Nortriptyline Hcl | Nortriptyline Hcl | 80 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 79 | 60 |
| Topiramate | Topiramate | 78 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 75 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 75 | suppressed |
| Carvedilol | Carvedilol | 70 | 11 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 70 | suppressed |
| Xtampza Er | Oxycodone Myristate | 70 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 69 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 69 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 65 | suppressed |
| Naproxen | Naproxen | 65 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 65 | suppressed |
| Ozempic | Semaglutide | 64 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 63 | 12 |
| Pravastatin Sodium | Pravastatin Sodium | 63 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 62 | 12 |
| Cephalexin | Cephalexin | 61 | 35 |
| Aripiprazole | Aripiprazole | 60 | suppressed |
| Januvia | Sitagliptin Phosphate | 59 | 12 |
| Clopidogrel | Clopidogrel Bisulfate | 58 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 56 | 15 |
| Morphine Sulfate Er | Morphine Sulfate | 55 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 55 | 13 |
| Jardiance | Empagliflozin | 54 | suppressed |
| Lamotrigine | Lamotrigine | 54 | suppressed |
| Ibuprofen | Ibuprofen | 52 | 15 |
| Symbicort | Budesonide/Formoterol Fumarate | 51 | 12 |
| Clonidine Hcl | Clonidine Hcl | 50 | 12 |
| Allopurinol | Allopurinol | 48 | suppressed |
| Synthroid | Levothyroxine Sodium | 48 | suppressed |
| Bupropion Xl | Bupropion Hcl | 47 | suppressed |
| Ezetimibe | Ezetimibe | 47 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 46 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 44 | 44 |
| Diazepam | Diazepam | 44 | suppressed |
| Lorazepam | Lorazepam | 44 | 14 |
| Ziprasidone Hcl | Ziprasidone Hcl | 44 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 43 | suppressed |
| Metolazone | Metolazone | 43 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 43 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 41 | suppressed |
| Nifedipine Er | Nifedipine | 41 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 40 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 39 | suppressed |
| Dexamethasone | Dexamethasone | 38 | 18 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 38 | 13 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 37 | suppressed |
| Olanzapine | Olanzapine | 37 | suppressed |
| Oxycontin | Oxycodone Hcl | 37 | suppressed |
| Mupirocin | Mupirocin | 36 | 20 |
| Ventolin Hfa | Albuterol Sulfate | 36 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 35 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 34 | suppressed |
| Levetiracetam | Levetiracetam | 33 | suppressed |
| Nabumetone | Nabumetone | 33 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 32 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 32 | suppressed |
| Methotrexate | Methotrexate Sodium | 32 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 32 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 31 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 31 | suppressed |
| Myrbetriq | Mirabegron | 31 | suppressed |
| Prednisone | Prednisone | 30 | 25 |
| Alendronate Sodium | Alendronate Sodium | 29 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 29 | suppressed |
| Fentanyl | Fentanyl | 29 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 28 | 25 |
| Ipratropium Bromide | Ipratropium Bromide | 28 | suppressed |
| Primidone | Primidone | 28 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 28 | suppressed |
| Trulicity | Dulaglutide | 28 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 27 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 27 | suppressed |
| Sucralfate | Sucralfate | 27 | suppressed |
| Gemfibrozil | Gemfibrozil | 26 | suppressed |
| Guanfacine Hcl | Guanfacine Hcl | 26 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 25 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 24 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 24 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 22 | suppressed |
| Spironolactone | Spironolactone | 22 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 22 | suppressed |
| Nystop | Nystatin | 21 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 21 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Levofloxacin | Levofloxacin | 20 | 16 |
| Carbamazepine | Carbamazepine | 19 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 19 | suppressed |
| Methocarbamol | Methocarbamol | 19 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 18 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 18 | suppressed |
| Fluconazole | Fluconazole | 18 | suppressed |
| Lansoprazole | Lansoprazole | 18 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 18 | suppressed |
| Tresiba | Insulin Degludec | 18 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 18 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Carisoprodol | Carisoprodol | 17 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 17 | suppressed |
| Finasteride | Finasteride | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 17 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 16 | suppressed |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Savella | Milnacipran Hcl | 16 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 15 | suppressed |
| Colchicine | Colchicine | 15 | suppressed |
| Estradiol | Estradiol | 15 | suppressed |
| Glimepiride | Glimepiride | 15 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 15 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 15 | 12 |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 15 | suppressed |
| Trandolapril | Trandolapril | 15 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 15 | suppressed |
| Xarelto | Rivaroxaban | 15 | suppressed |
| Advocate Pen Needles | Pen Needle, Diabetic | 14 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 14 | suppressed |
| Chlorthalidone | Chlorthalidone | 14 | suppressed |
| Methadone Hcl | Methadone Hcl | 14 | suppressed |
| Nystatin | Nystatin | 14 | 11 |
| Risperidone | Risperidone | 14 | suppressed |
| Testosterone | Testosterone | 14 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Lidocaine | Lidocaine | 13 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 13 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Etodolac | Etodolac | 12 | suppressed |
| Felodipine Er | Felodipine | 12 | suppressed |
| Glipizide | Glipizide | 12 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 12 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 12 | suppressed |
| Mounjaro | Tirzepatide | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Salsalate | Salsalate | 12 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 12 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 12 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 11 | suppressed |
| Calcitriol | Calcitriol | 11 | suppressed |
| Humulin R | Insulin Regular, Human | 11 | suppressed |
| Irbesartan | Irbesartan | 11 | suppressed |
| Matzim La | Diltiazem Hcl | 11 | suppressed |
| Novolog | Insulin Aspart | 11 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Triazolam | Triazolam | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $32.39 · 2 records | Dexcom, Inc. | Dexcom G6 Transmitter, VRAYLAR | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error